Fred Tejada Secures Board Seat at Nu-Med Plus with 9.7% Stake
Fred Tejada disclosed a 9.7% stake in Nu-Med Plus, Inc. (NUMD), gaining a board seat and significant voting power. He entered a Voting Agreement to influence corporate actions, including a reverse stock split and board restructuring. Tejada's super-voting shares and proxy control key shareholder votes.
